Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

A PK and Salvage Study for Children With HIV-infection

NCT00476359 ·Status: COMPLETED ·Phase: PHASE4

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

NCT00940771 ·Status: COMPLETED ·Phase: PHASE4

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

NCT01139905 ·Status: COMPLETED ·Phase: PHASE2

Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation

NCT03836833 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed

NCT04012931 ·Status: COMPLETED ·Phase: PHASE2

PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)

NCT01099579 ·Status: COMPLETED ·Phase: PHASE3

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

NCT00006604 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

NCT00090779 ·Status: TERMINATED ·Phase: PHASE2

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

NCT01138605 ·Status: COMPLETED ·Phase: PHASE2

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children

NCT02383108 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children

NCT01982396 ·Status: COMPLETED ·Phase: PHASE1

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

NCT01237444 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

NCT00476983 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers

NCT01796431 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

NCT00357552 ·Status: COMPLETED ·Phase: NA

PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers

NCT01108926 ·Status: COMPLETED ·Phase: PHASE1

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

NCT00004578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

NCT00071097 ·Status: COMPLETED ·Phase: PHASE2

Lopinavir (LPV) Dose Reduction

NCT01159275 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

NCT02348177 ·Status: COMPLETED ·Phase: PHASE4

A Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult Participants

NCT04827134 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

NCT00915655 ·Status: COMPLETED ·Phase: PHASE2

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

NCT00273273 ·Status: COMPLETED

Lopinavir/Ritonavir Monotherapy in Children

NCT00626301 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics of Once Daily Darunavir/Ritonavir in HIV-infected Children

NCT02285478 ·Status: COMPLETED